Nickolay V. Kukekov

Dr. Kukekov received his Ph.D. in Neuroscience from Columbia University, College of Physicians & Surgeons in New York City. The focus of his research was the molecular mechanisms underlying programmed cell death of neuronal cells exposed to various pro-apoptotic conditions i.e. hypoxia, cytotoxic drugs, amyloid-beta, etc. After his thesis defense and post-doctoral position at Columbia, he spent 15 years on Wall Street, where he held a number of healthcare investment banking positions. For over a decade, he was a founding partner at Highline Research Advisors, served as a Managing Director at Summer Street Research Partners and at Paramount BioCapital, and was a Vice President at Rodman and Renshaw.

Dr. Kukekov received his undergraduate degree from the University of Colorado at Boulder in molecular, cellular and developmental biology and is a recipient of multiple research scholarship awards and publications in peer reviewed articles in leading scientific journals.